Therapy News and Research

RSS

Loyola announces plans to produce CAR-T cells for treating cancer

Loyola University Chicago and Loyola Medicine have announced plans to become the first Chicago center to produce cancer-fighting CAR-T cells to treat leukemia and lymphoma.

28 Sep 2018

Broadly neutralizing antibodies offer a new approach to treating HIV infection

A new generation of broadly neutralizing antibodies provides a novel approach to treating HIV infection.

28 Sep 2018

Rochester and Minnesota team receives grant to create center for child maltreatment studies

The University of Rochester's Mt. Hope Family Center, in conjunction with the University of Minnesota's Institute for Translational Research in Children's Mental Health, has received a multi-million-dollar grant to create a national center for child maltreatment studies, becoming one of only three academic institutional partnerships in the United States to receive this prestigious award from the National Institutes of Health.

28 Sep 2018

CNL, TRIUMF team up to enable revolutionary cancer treatment

TRIUMF, Canada's particle accelerator center, and Canadian Nuclear Laboratories, Canada's premier nuclear science and technology organization, are pleased to announce that they have agreed to pursue a strategic partnership around the commercial production of Actinium-225, a rare medical isotope that has the potential to serve as the basis of new ground-breaking cancer treatments.

28 Sep 2018

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved VIZIMPRO [vih-ZIM-pro] (dacomitinib), a kinase inhibitor for the first-line treatment of patients with metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test.

28 Sep 2018

Diet comprising of soups and shakes may combat obesity

According to a new study a diet comprising of soups and shakes replacing regular food could help people with obesity to lose weight significantly and sustain it over time.

27 Sep 2018

Non-small cell lung cancer patients survive longer when treated with durvalumab

Non-small cell lung cancer patients survive longer when their treatment includes durvalumab following platinum-based chemoradiotherapy, according to research led by Moffitt Cancer Center.

27 Sep 2018

Study aims to investigate antimicrobial resistance of uropathogenic E. coli from elderly patients

Urinary Tract Infection is a common cause of morbidity and mortality in older adults. Escherichia coli is one of the bacterial agents with higher prevalence in community-acquired and health care associated urinary infections in elderly patients.

27 Sep 2018

Researchers develop new mathematical technique to study brain waves

A U.S. Army Research Laboratory scientist has collaborated with a team of researchers from the University of North Texas to develop a new data processing technique that uses electroencephalogram, or EEG, time series variability as a measure of the state of the brain.

27 Sep 2018

Fewer daylight hours during late pregnancy may increase risk of postpartum depression

Women in late pregnancy during darker months of the year may have a greater risk of developing postpartum depression once their babies are born.

27 Sep 2018

Cidara initiates Phase 3 clinical trial to evaluate efficacy, safety of rezafungin to treat invasive candidiasis

Cidara Therapeutics, Inc., a biotechnology company developing novel anti-infectives including immunotherapies, today announced that the first trial site has been activated for ReSTORE, a Phase 3 clinical trial evaluating the efficacy and safety of the company's lead antifungal, rezafungin, to treat candidemia and invasive candidiasis.

27 Sep 2018

FLX Bio treats first patient in its Phase 1/2 clinical trial of FLX475 for treating various advanced cancers

FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.

27 Sep 2018

CytoSen receives favorable response from FDA to its pre-IND meeting package for CSTD002-NK

CytoSen Therapeutics, a private biopharmaceutical company accelerating innovation in Natural Killer cell therapy, today announced it has received a favorable response from the U.S. Food and Drug Administration to its pre-Investigational New Drug meeting package for the proposed Phase 2 trial of CytoSen's adoptive NK cell therapy, CSTD002-NK, for the reduction of relapse in high risk acute myeloid leukemia or myelodysplastic syndrome in patients undergoing haploidentical hematopoietic stem cell transplantation.

27 Sep 2018

Cornwall and Chongqing Haifu partners to introduce HIFU tumor therapy system

Cornwall Medical Group enters a strategic partnership with the world's leading medical equipment and integrated solutions provider, Chongqing Haifu Medical Technology Co., Ltd., to introduce innovative high-intensity focused ultrasound tumor therapy system to Hong Kong, positioned to be the first minimally-invasive & non-invasive center in town.

27 Sep 2018

OrthoSera presents first-in-man study results of hyperacute serum in knee osteoarthritis

OrthoSera GmbH, an orthobiologics company developing serum-based solutions for musculoskeletal indications announces results of its first-in-man pilot clinical study of hyperacute serum on 36 patients in knee osteoarthritis.

27 Sep 2018

Novel therapy technique double rate of upper limb recovery in stroke patients

A novel therapy technique invented by researchers at The University of Texas at Dallas has been shown in a pilot study to double the rate of upper limb recovery in stroke patients, a leap forward in treating the nearly 800,000 Americans who suffer strokes each year.

27 Sep 2018

EU conducts research into mechanisms and effects of atrial fibrillation

Atrial fibrillation is the most common type of irregular heartbeat, or cardiac arrhythmia, affecting 2-3 % of the European population and as many as one in 10 people over the age of 80.

27 Sep 2018

Lower clinical trial enrollment associated with relapse risk in AYA leukemia patients

Adolescent and young adult patients with acute lymphoblastic leukemia were significantly more likely to relapse than pediatric ALL patients, and factors including lower clinical trial enrollment and shorter duration of therapy were associated with relapse.

27 Sep 2018

Auto-FMT found to be safe, effective way to replenish beneficial gut bacteria in cancer patients

Researchers at Memorial Sloan Kettering Cancer Center have shown that autologous fecal microbiota transplantation (auto-FMT) is a safe and effective way to help replenish beneficial gut bacteria in cancer patients who require intense antibiotics during allogenic hematopoietic stem cell transplantation.

27 Sep 2018

Antibiotic resistance in cystic fibrosis linked to decreased microbial diversity and pulmonary function

A defective gene causes thick, sticky mucus to build up in the lungs of patients with cystic fibrosis. There, it traps bacteria, causing patients to develop frequent lung infections that progressively damage these vital organs and impair patients' ability to breathe.

27 Sep 2018

Therapy News and Research

Loyola announces plans to produce CAR-T cells for treating cancer

Broadly neutralizing antibodies offer a new approach to treating HIV infection

Rochester and Minnesota team receives grant to create center for child maltreatment studies

CNL, TRIUMF team up to enable revolutionary cancer treatment

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Diet comprising of soups and shakes may combat obesity

Non-small cell lung cancer patients survive longer when treated with durvalumab

Study aims to investigate antimicrobial resistance of uropathogenic E. coli from elderly patients

Researchers develop new mathematical technique to study brain waves

Fewer daylight hours during late pregnancy may increase risk of postpartum depression

Cidara initiates Phase 3 clinical trial to evaluate efficacy, safety of rezafungin to treat invasive candidiasis

FLX Bio treats first patient in its Phase 1/2 clinical trial of FLX475 for treating various advanced cancers

CytoSen receives favorable response from FDA to its pre-IND meeting package for CSTD002-NK

Cornwall and Chongqing Haifu partners to introduce HIFU tumor therapy system

OrthoSera presents first-in-man study results of hyperacute serum in knee osteoarthritis

Novel therapy technique double rate of upper limb recovery in stroke patients

EU conducts research into mechanisms and effects of atrial fibrillation

Lower clinical trial enrollment associated with relapse risk in AYA leukemia patients

Auto-FMT found to be safe, effective way to replenish beneficial gut bacteria in cancer patients

Antibiotic resistance in cystic fibrosis linked to decreased microbial diversity and pulmonary function

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News